The anti-cancer and cancer treatment sector surged, and Ruizhi Pharmaceutical hit the daily limit.

2026-04-03 00:10:40

Abstract generation in progress

April 01 news. As of 14:21, the anti-cancer and cancer-treatment sector surged. Leading gainers hit the daily limit, including RuiZhi Pharmaceutical, Peking University Medicine, and Haixin Co., Ltd. Individual stocks such as Taienkang, Shutaishen, XinLiTai, Boteng Co., Ltd., Changshan Pharmaceutical, and Cape Bio saw the biggest percentage gains.

Statement: The market carries risk; investment requires caution. This article is automatically published based on third-party databases and does not represent any views from Sina Finance. Any information appearing in this article is for reference only and does not constitute personal investment advice. If there is any discrepancy, please refer to the actual announcements. If you have any questions, please contact biz@staff.sina.com.cn.

A wealth of information and precise analysis—available on the Sina Finance app

责任编辑：小浪快报

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.